Apoptosis and cancer risk assessment

Mutation Research - Reviews in Genetic Toxicology

Volumn 365, Issue 1-3, 1996, Pages 71-90

  Goldsworthy, Thomas L ^a   Conolly, Rory B ^a   Fransson Steen, Ronny ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

cancer model; hepatocarcinogenesis; proliferation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CANCER GROWTH; CANCER RISK; CELL DEATH; CELL SURVIVAL; LIVER CARCINOGENESIS; MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; RISK ASSESSMENT;

ANIMALIA; RODENTIA;

EID: 0029855223     PISSN: 01651110     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1110(96)90013-5     Document Type: Article

References (95)

1. Alison M.R., Sarraf C.E. Apoptosis: regulation and relevance to toxicology. Hum. Exp. Toxicol. 14:1995;234-247.
2. Ansari B., Coates P.J., Greenstein B.D., Hall P.A. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J. Pathol. 170:1993;1-8.
3. Arley N., Iverson S. On the mechanism of experimental carcinogenesis, III, Further development of the hit theory of carcinogenesis. Acta Pathol. Microbiol. Scand. 30:1952;21-53.
4. Armitage P., Doll R. The age distribution of cancer and a multistage theory of cancer. Br. J. Cancer. 8:1954;1-12.
5. Barinaga M. Cell death studies yield cancer clues. Science. 259:1993;760-763.
6. Bellamy C.O.C., Malcomson R.D.G., Harrison D.J., Wyllie A.H. Cell death in health and disease: the biology and regulation of apoptosis. Cancer Biol. 6:1995;3-16.
7. Bursch W., Lauer B., Timmermann-Trosiener I., Barthel G., Schuppler J., Schulte-Hermann R. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis. 5:1984;453-458.
8. Bursch W., Taper H.S., Lauer B., Schulte-Hermann R. Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch. B Cell Pathol. 50:1985;153-166.
9. Bursch W., Paffe S., Putz B., Barthel G., Schulte-Hermann R. Determination of the length of the histological stages of apoptosis in normal and in altered hepatic foci of rats. Carcinogenesis. 11:1990;847-853.
10. Bursch W., Oberhammer F., Schulte-Hermann R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol. Sci. 13:1992;245-251.
11. Bursch W., Oberhammer F., Jirtle R.L., Askari M., Sedivy R., Grasl-Kraupp B., Purchio A.F., Schulte-Hermann R. Transforming growth factor-β1 as a signal for induction of cell death by apoptosis. Br. J. Cancer. 67:1993;531-536.
12. Butterworth B.E., Goldsworthy T.L. The role of cell proliferation in multistage carcinogenesis. Proc. Soc. Exp. Biol. Med. 198:1991;683-688.
13. Butterworth B.E., Popp J.A., Conolly R.B., Goldsworthy T.L. Chemically induced cell proliferation in carcinogenesis. Vainio H., Magee P.N., McGregory D.B., McMichael A.J. Mechanism of Carcinogenesis in Risk Identification. IARC Publication. 116:1992;279-305.
14. Canman C.E., Kastan M.B. Induction of apoptosis by tumor suppressor genes and oncogenes. Semin. Cancer Biol. 6:1995;17-26.
15. Coates P.J. Molecular methods for the identification of apoptosis in tissues. J. Histotechnol. 17:1994;261-267.
16. Cohen S., Ellwein L. Cell proliferation in carcinogenesis. Science. 249:1990;1007-1011.
17. Columbano A., Ledda-Columbano G.M., Ennas M.G., Curto M., Chelo A., Pani P. Cell proliferation and promotion of rat liver carcinogenesis: different effect of hepatic regeneration and mitogen induced hyperplasia on the development of enzyme-altered foci. Carcinogenesis. 11:1990;771-776.
18. Conolly R.B. Estimating uncertainty in pharmacodynamic models using chloroform as an example. Fundam. Appl. Toxicol. 24:1995;24-35.
19. Conolly R.B., Kimbell J.S. Computer simulation of cell growth governed by stochastic processes: application to clonal growth cancer models. Toxicol. Appl. Pharmacol. 124:1994;284-295.
20. Craig R.W. The bcl-2 gene family. Semin. Cancer Biol. 6:1995;35-44.
21. Crump K.S. Limitations of biological models of carcinogenesis for low-dose extrapolation. Risk Anal. 14:1994;883-886.
22. Crump K.S., Guess H.A., Deal K.L. Confidence intervals and test of hypotheses concerning dose response relations inferred from animal carcinogenicity data. Biometrics. 33:1977;437-451.
23. Cunningham M.L. Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens. Mutation Res. 1996;. this issue.
24. Cunningham M.L., Matthews H.B. Relationship of hepatocarcinogenicity and hepatocellular proliferation induced by mutagenic noncarcinogens vs. carcinogens. Toxicol. Appl. Pharmacol. 110:1991;505-513.
25. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Motz M.A., Lassota P., Traganes F. Features of apoptotic cells measured by flow cytometry. Cytometry. 13:1992;795-808.
26. Dewanji A., Venzon D.J., Moolgavkar S.H. A stochastic two-stage model for cancer risk assessment, II. The number and size of premalignant clones. Risk Anal. 9:(2):1989;179-187.
27. Dragan Y.P., Sargent L., Xu Y.-D., Xu Y.-H., Pitot H.C. The initiation-promotion-progression model of rat hepatocarcinogenesis (43511C). Proc. Soc. Exp. Biol. Med. 202:1993;16-24.
28. Eastman A. Apoptosis: A product of programmed and unprogrammed cell death. Toxicol. Appl. Pharmacol. 121:1993;160-164.
29. Eastman A. Survival of factors, intracellular signal transduction, and the activation of endonucleases in apoptosis. Semin. Cancer Biol. 6:1995;45-52.
30. Ellwein L.B., Cohen S.M. A cellular dynamics model of experimental bladder cancer: Analysis of the effect of sodium saccharin in the rat. Risk Anal. 8:1988;215-221.
31. Fisher J.C., Holloman J.H. A new hypothesis for the origin of cancer foci. Cancer. 4:1951;916-918.
32. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
33. Gill J.H., Molloy C.A., Shoesmith K.J., Bayly A.C., Roberts R.A. The rodent non-genotoxic hepatocarcinogen Nafenopin and EGF alter the mitosis/apoptosis balance promoting hepatoma cell clonal growth. Cell Death Differ. 2:1995;211-217.
34. Goldsworthy T.L., Hanigan M.H., Pitot H.C. Models of hepatocarcinogenesis in the rat - contrasts and comparisons. Crit. Rev. Toxicol. 17:1986;61-89.
35. Goldsworthy T.L., Fransson-Steen R., Maronpot R.R. Importance of and approaches to quantification of hepatocyte apoptosis. Toxicol. Pathol. 24:1996;24-35.
36. Gorczyca W., Gang J., Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:1993;1945-1951.
37. Grasl-Kraupp B., Bursch W., Ruttkay-Nedecky B., Wagner A., Lauer B., Schulte-Hermann R. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc. Natl. Acad. Sci. USA. 91:1994;9995-9999.
38. Harrington E.A., Fanidi A., Evan G.I. Oncogenes and cell death. Curr. Opin. Genet. Dev. 4:1994;120-129.
39. Hockenbury D. Defining apoptosis. Am. J. Pathol. 146:1995;16-19.
40. Hoffman B., Liebermann D.A. Molecular controls of apoptosis: differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene. 9:1994;1807-1812.
41. Hully J.R., Chang L., Schwall R.H., Widmer H.R., Terrell T.G., Gillett N.A. Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology. 20:1994;854-862.
42. James N.H., Roberts R.A. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes. Carcinogenesis. 15:1994;2687-2694.
43. Jirtle R.L., Carr B.I., Scott C.D. Modulation of insulin-like growth factor-II/annose 6-phosphate receptors and transforming growth factor-β1 during liver regeneration. J. Biol. Chem. 266:1991;22444-22450.
44. Kane A.B. Redefining cell death. Am. J. Pathol. 146:1995;1-2.
45. Kaneko Y., Tsukamoto A. Apoptosis and nuclear levels of p53 protein and proliferating cell nuclear antigen in human hepatoma cells cultured with tumor promoters. Cancer Lett. 91:1995;11-17.
46. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 68:1972;239-257.
47. Kong J., Ringer P. Quantitative in situ image analysis of apoptosis in well and poorly differentiated tumors from rat liver. Am. J. Pathol. 147:1995;1626-1632.
48. Kramer D.A., Conolly R.B. Computer simulation of clonal growth cancer models, I. Parameter estimation using an iterative absolute bisection algorithm. Risk Anal. 1995;. submitted.
49. Ledda-Columbano G.M., Coni P., Curto M., Giacomini L., Faa G., Oliverio S., Piacentini M., Columbano A. Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am. J. Pathol. 139:1991;1099-1109.
50. Levin S. A toxicologic pathologist's view of apoptosis or I used to call it necrobiosis, but now I'm singing the apoptosis blues. Toxicol. Pathol. 23:1995;533-539.
51. Luebeck E.G., Moolgavkar S.H., Buchmann A., Schwarz M. Effects of polychlorinated biphenyls in rat liver: quantitative analysis of enzyme-altered foci. Toxicol. Appl. Pharmacol. 111:1991;469-484.
52. Majno G., Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am. J. Pathol. 146:1995;3-15.
53. Maronpot R.R., Foley J.F., Takahashi K., Goldsworthy T.L., Clark G., Tritscher A., Portier C., Lucier G. Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic biochemical and cell proliferation endpoints. Environ. Health Perspect. 101:1993;634-642.
54. McConkey D.J., Orrenius S. Signal transduction pathways to apoptosis. Trends Cell Biol. 4:1994;370.
55. Mills J.J., Chari R.S., Boyer I.J., Gould M.N., Jirtle R.Y. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res. 55:1995;979-983.
56. Moolgavkar S.H. Cell proliferation and carcinogenesis models: general principles with illustrations from the rodent liver system, Environ. Health Perspect. 101:(Suppl. 5):1993;91-94.
57. Moolgavkar S.H. Biological models of carcinogenesis and quantitative cancer risk assessment. Risk Anal. 14:1994;879-882.
58. Moolgavkar S.H., Venzon D.J. Two-event models for carcinogenesis: incidence curves for childhood and adult tumors. Math. Biosci. 47:1979;55-77.
59. Moolgavkar S.H., Knudson A.G. Jr. Mutation and cancer: a model for human carcinogenesis. J. Natl. Cancer Inst. 66:1981;1037-1052.
60. Moolgavkar S.H., Luebeck E.G. Interpretation of labeling indices in the presence of cell death. Carcinogenesis. 13:1992;1007-1010.
61. Moolgavkar S.H., Luebeck E.G., de Gunst M., Port R.E., Schwarz M. Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments - I. Single agent regimen. Carcinogenesis. 11:(8):1990;1271-1278.
62. Moser G.J., Wolf D.C., Harden R., Standeven A.M., Mills J., Jirtle R.L., Goldsworthy T.L. Cell proliferation and negative growth factor regulation in mouse liver foci. Carcinogenesis. 1996;. in press.
63. Nagata S., Golstein P. The fas death factor. Science. 267:1995;1449-1456.
64. Nordling C.O. A new theory on cancer inducing mechanism. Br. J. Cancer. 7:1953;68-72.
65. Nunez G., Clarke M.F. The bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol. 4:1994;339-403.
66. Oberhammer F.A., Roberts R.A. Apoptotis: a widespread process involved in liver adaptation and carcinogenesis. Arias I.M., Boyer J.L., Fausto N., Jakoby W.B., Schachter D.A., Shafritz D.A. The Liver: Biology and Pathobiology. 3rd Edn. 1994;1547-1556 Raven Press, New York.
67. Oberhammer F.A., Pavelka M., Sharma A., Tiefenbacher R., Purchio A., Bursch W., Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regression liver by transforming growth factor b1. Proc. Natl. Acad. Sci. USA. 89:1992;5408-5412.
68. Olive P.L., Banáth J.P. Sizing highly fragmented DNA in individual apoptotic cells using the comet assay and a DNA crosslinking agent. Exp. Cell Res. 221:1995;19-26.
69. Pitot H.C. Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu. Rev. Pharmacol. Toxicol. 30:1990;465-500.
70. Pitot H.C., Sirica A.E. The stages of initiation and promotion in hepatocarcinogenesis. Biochim. Biophys. Acta. 605:(2):1980;191-215.
71. Portier C.J. Biostatistical issues in the design and analysis of animal carcinogenicity experiments. Environ. Health Perspect. 102:(Suppl. 1):1994;5-8.
72. Potter V.R. Initiation and promotion in cancer formation: the importance of studies on intercellular communication. Yale J. Biol. Med. 53:1980;367-384.
73. Pritchard D.J., Butler W.H. Apoptosis - the mechanism of cell death in dimethylnitrosamine-induced hepatotoxicity. J. Pathol. 158:1989;253-260.
74. Reynolds E.S., Kanz M.F., Chieco P., Moslen M.T. 1,1-Dichloroethylene: an apoptotic hepatotoxin? Environ. Health Perspect. 57:1984;313-320.
75. Roberts R.A., Soames A.R., Gill J.H., James N.H., Wheeldon E.B. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis. 16:1995a;1693-1698.
76. Roberts R.A., Soames A.R., James N.H., Gill J.H., Wheeldon E.B. Dosing-induced stress causes hepatocyte apoptosis in rats primed by the rodent nongenotoxic hepatocarcinogen cyproteron acetate. Toxicol. Appl. Pharmacol. 135:1995b;192-199.
77. Satoh K., Hatayama I., Tateoka N., Tamai K., Shimizu T., Tatematsu M., Ito N., Sato K. Transient induction of single GST-P positive hepatocytes by DEN. Carcinogenesis. 10:1989;2107-2111.
78. Savill J., Dransfield I., Hogg N., Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature. 343:1990;170-173.
79. Schulte-Hermann R., Bursch W., Kraupp-Grasl B., Oberhammer F., Wagner A., Jirtle R. Cell proliferation and apoptosis in normal liver and preneoplastic foci. Environ. Health Perspect. 101:(Suppl. 5):1993;87-90.
80. Schwartzman R.A., Cidlowski J.A. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrin. Rev. 14:1993;133-151.
81. Snyder R.D., Pullman J., Carter J.H., Carter H.W., DeAngelo A.B. In vivo administration of dichloroacetic acid suppresses spontaneous apoptosis in murine hepatocytes. Cancer Res. 55:1995;3702-3705.
82. Standeven A.S., Wolf D.C., Goldsworthy T.L. Promotion of hepatic preneoplastic lesions in male B6C3F1 mice by unleaded gasoline. Environ. Health Perspect. 10:1995;696-700.
83. Steller H. Mechanisms and genes of cellular suicide. Science. 267:1995;1445-1449.
84. Stinchcombe S., Buchmann A., Bock K.W., Schwarz M. Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumor promotion in rat liver. Carcinogenesis. 16:1995;1271-1275.
85. Terada T., Nakanuma Y. Detection of apoptosis and expression of apoptosis-related proteins during human intra-hepatic bile duct development. Am. J. Pathol. 146:1995;67-74.
86. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
87. Thorslund T.W., Brown C.C., Charnley G. Biologically motivated cancer risk models. Risk Anal. 7:1987;109-119.
88. Trosko J.E., Goodman J.I. Intercellular communication may facilitate apoptosis: implications for tumor promotion. Mol. Carcinogen. 11:1994;8-12.
89. Wakefield L.M., Winokur T.S., Hollands R.S., Chrostopherson K., Levinson A.D., Sporn M.B. Recombinant latent transformed growth factor beta has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J. Clin. Invest. 86:1990;1976-1984.
90. Wallig M.A., Kore A.M., Crawshaw J., Jeffrey E.H. Separation of the toxic and glutathione-enhancing effects of the naturally occurring nitrile, cyanohydroxybutene. Fundam. Appl. Toxicol. 19:1992;598-606.
91. Wheeldon E.B., Williams S.M., Soames A.R., James N.H., Roberts R.A. Quantitation of apoptotic bodies in rat liver by in situ end labeling (ISEL): correlation with morphology. Toxicol. Pathol. 23:1995;410-415.
92. White K., Grether M.E., Abrams J.M., Yong L., Farrell K., Steller H. Genetic control of programmed cell death in drosophila. Science. 264:1994;677-683.
93. Wijseman J.H., Jonker R.R., Keijer R., Van de Velde C.J.V., Cornelisse C.J., Van Dierendonck J.H. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J. Histochem. Cytochem. 41:1993;7-12.
94. Wyllie A.H., Kerr J.F.R., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-307.
95. Yamasaki H. Gap junctional intercellular communication and carcinogenesis. Carcinogenesis. 11:1990;1051-1058.